Email ID
Password
Scrip   
Tamiflu drives Chugai to record results
04 February 2010
Ian Haydock

Roche's Japanese subsidiary, Chugai, has logged record sales and profits on the back of sharply higher domestic sales of the flu product Tamiflu (oseltamivir).

Revenues from the neuraminidase inhibitor surged more than nine-fold to ¥76.2 billion ($842.9 million) in the fiscal year ended...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36